| COVID-19 |
1 |
1 |
| Plasma |
0 |
0.95 |
| Acute Respiratory Distress Syndrome |
0 |
0.48 |
| Biologic Therapy |
0 |
0.47 |
| Severe Acute Respiratory Syndrome |
0 |
0.15 |
| Transfusion |
0 |
0.15 |
| Transfusion Medicine |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.11 |
| Monoclonal Antibody |
0 |
0.11 |
| Peer Review |
0 |
0.11 |
| Microbiome |
0 |
0.1 |
| Vaccines |
0 |
0.1 |
| Wound Management |
0 |
0.1 |
| Hospital |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Brain |
0 |
0.04 |
| Dorsum |
0 |
0.04 |
| Immunology |
0 |
0.04 |
| Injury |
0 |
0.04 |
| Microbiology |
0 |
0.04 |
| Targeted Cancer Therapy |
0 |
0.04 |